Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Cancer Cell International, 05/11/2012

The differential expression of paralemmin in a subset of breast cancers suggests the existence of variation in membrane dynamics that may be exploited to improve diagnosis or provide a therapeutic target.

Print Article Summary Cat 2 CME Report